Analysis of factors and individual differences in clinical efficacy and pharmacokinetics of enoxaparin,fondaparinux.

Analysis of factors and individual differences in clinical efficacy and pharmacokinetics of enoxaparin,fondaparinux. - Analysis of factors and individual differences in clinical efficacy and pharmacokinetics of enoxaparin,fondaparinux.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000006241

Enrollment

100

Registered

2011-08-28

Start date

2011-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

knee replacement surgery

Interventions

Fondaparinux Enoxaparin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients undergoing knee replacement surgery

Exclusion criteria

Exclusion criteria: under twenty years. with a history of DVT and PTE. With the disease have abnormal clotting. Patient's written consent not obtained. contraindications to enoxaparin or fondaparinux. The patient has been administered warfarin. Patients with other treating physician deems inappropriate.

Design outcomes

Primary

Measure	Time frame
effectiveness and relevance of pharmacokinetics and safety.	—

Countries

Japan

Contacts

Public Contactshibata soichi

Pharmacy Pharmacy

shibasoh@insti.kitasato-u.ac.jp03-3444-6161

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026